Skip to content
Catalyst

PapersPMID:33586367

Elevated Urate Levels Do Not Alter Bone Turnover Markers: Randomized Controlled Trial of Inosine Supplementation in Postmenopausal Women.

Arthritis & rheumatology (Hoboken, N.J.)2021The record ↗

  1. Finding, very limited evidenceraisesSerum uric acid

What moved

1 findingHow to read these marks →
  • “Administration of inosine led to a significant increase in serum urate concentration over the study period (P < 0.0001 for all follow-up time points).”
    Study
    RCT
    Duration
    6 months
    Dose studied
    inosine supplements for 6 months; dose not stated in the abstract
    Population
    Postmenopausal women without osteoporosis, previous fragility fracture, bisphosphonate therapy, gout, kidney stones or urine pH of 5.0 or below

Study record

Design
randomised controlled trial
Species
human
Population
postmenopausal women without osteoporosis, previous fragility fracture, bisphosphonate therapy, gout, kidney stones or a urine pH level of ≤5.0
Participants
120
Comparator
placebo
Duration
183 days
Endpoints measured
5